PCH
DYN icon

Polar Capital Holdings’s Dyne Therapeutics DYN Stock Holding History

Polar Capital Holdings’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.6M Buy
1,359,169
+90,038
+7% +$1.55M 0.09% 131
2025
Q4 		$24.8M Buy
1,269,131
+739,743
+140% +$14M 0.1% 142
2025
Q3 		$6.7M Buy
+529,388
New +$6.04M 0.03% 213
2023
Q3 		– Sell
-500,000
Closed -$5.63M – 287
2023
Q2 		$5.63M Buy
+500,000
New +$5.9M 0.03% 225

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Polar Capital Holdings's DYN Position: Q1 2026 in Review

Polar Capital Holdings increased its Dyne Therapeutics (DYN) stake by 7.1% in Q1 2026, buying an estimated $1.55M and bringing the position to 1,359,169 shares worth $24.6M. The position accounts for 0.09% of the portfolio, ranked #131.

Polar Capital Holdings first reported a position in DYN in Q2 2023 and has held it in 4 quarters since. The position peaked at $24.8M in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Polar Capital Holdings held 1,359,169 shares of Dyne Therapeutics worth $24.6M as of Q1 2026.
  • Polar Capital Holdings bought 90,038 Dyne Therapeutics shares in Q1 2026, an estimated $1.55M.
  • Dyne Therapeutics made up 0.09% of Polar Capital Holdings's portfolio in Q1 2026, its #131 holding.
  • Polar Capital Holdings first reported a position in Dyne Therapeutics in Q2 2023 and has held it in 4 quarters since.
  • Polar Capital Holdings's Dyne Therapeutics position peaked at $24.8M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Polar Capital Holdings's 13F filing for Q1 2026, filed 15 May 2026.